Company Information & Drug Savings for Pharming Healthcare Medications

Pharming Group is a Dutch biopharmaceutical company focused on rare diseases and unmet medical needs. The company developed Ruconest (conestat alfa), a recombinant human C1 esterase inhibitor for treating acute hereditary angioedema (HAE) attacks. Pharming’s expertise in recombinant protein production addresses rare genetic disorders.